#pds-biotechnology

PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17

PDS Biotechnology Corporation has discussed its PDS-0301 immunocytokine and its role in treating metastatic colorectal cancer. The company has presented a slideshow highlighting the potential of this treatment. This development may impact the biotechnology sector and the treatment of colorectal cancer.